Skip to content
★ Sign in to follow
Beijing Science Sun Pharmaceutical Co., Ltd. logo

Beijing Science Sun Pharmaceutical Co., Ltd. Stock: price and insider trades · China

赛升药业

CN·Mcap CN¥3.7BHealth Care

Beijing Science Sun Pharmaceutical Co., Ltd.: what insiders have been doing

Only a handful of insider records exist for Beijing Science Sun Pharmaceutical Co., Ltd., the last one from 19 November 2021, too few to describe a trend. These figures are compiled from regulatory filings published by SSE / SZSE (CSRC). They describe what insiders did and are not a recommendation.

Insider Decl.
1
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
€14M
1 ops. · all time

This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.

Fundamental score
Ranked 16,265 of 26,897 companies
45.1
score / 100
Value
32
Quality
58
FCF yld-2.0%
Earn yld0.4%
EV/EBITDA·
ROE-5.5%
Gross mgn65%
Net mgn3.6%
Debt/EBITDA0.3x
Pillars2/3

Transparent value + quality ranking, distinct from the insider signal.

Financial data

as of FY 2025

FY ended December 2025 · cache

CN¥7.72
Analyst consensus
·
Income statement
RevenueCN¥404.7M
Gross profitCN¥263.5M65% margin
EBITDACN¥60.1M15% margin
Net incomeCN¥14.6M-45.5% margin
Valuation
P/Book1.2x
Beta0.24
Balance sheet & cash
Market capCN¥3.7B
Total debtCN¥19.9M
Free Cash Flow-CN¥73.2M
Debt / Equity0%
Profitability & ownership
ROE-5.5%
ROA-0.4%
% insiders57.6%
% institutions0.6%
Last declaration on 19 November 2021
Declarations1 total
  • ▼
    董事,副总经理,财务总监Executives
    99M CNY30SZSE
    9,600,000 shares100.0% of flowA股XSHESZSE:173000005093969900

1 of 1 declaration

About Beijing Science Sun Pharmaceutical Co., Ltd.

赛升药业 is a company in the healthcare and pharmaceutical sector, listed on the XSHE market. It focuses on the development and production of innovative drugs.

Recent ranked signals in the same sector

Purchases our model currently ranks for the recommendations list.

All recommendations